Fracture Related Infection

4

Review clinical trials related to Fracture Related Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Comparison of Debridement, Antibiotic, Implant Retention and Implant Exchange in Early-stage Fracture-related Infections

This study aims to compare the clinical outcomes of debridement, antibiotics, and implant retention (DAIR) and implant removal/replacement methods used in the treatment of fracture-related infections, and to determine the infection-free fracture healing rates and the factors affecting treatment success.

Participants needed: 75
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Antalya Health Sciences UniversityUpdated: Jun 25, 2026Locations: 1
Eligibility criteria

internal fixation after fracture [+4]

Under 18 years old patients [+9]

Status: Not yet recruiting

Hyperbaric Oxygen Therapy as Adjunctive Treatment for Fracture-Related Infection

A fracture-related infection (FRI) is a difficult to treat condition in which a bone fracture and surrounding tissues are infected. This results in impaired healing and ongoing symptoms such as pain, wound leakage and swelling, which affects patients' functioning and quality of life. Despite adequate treatment in the form of extensive surgical debridement and long-term antibiotics, it is hard to obtain infection eradication. This pilot, non-blinded, randomized controlled trial (RCT) will assess the feasibility of a subsequent, larger RCT, in which hyperbaric oxygen therapy (HBOT) will be investigated as potential treatment modality for FRI in adjunction to standard care. HBOT induces an increased oxygen tension in the body and thereby inhibits inflammation and the growth of several bacteria. Furthermore, it stimulates bone and blood vessel formation. Therefore, HBOT might be of added value in the treatment of FRI. Data on process-related outcomes, patient-reported outcome measures, and clinical parameters are obtained during this pilot study to determine whether a subsequent study investigating the efficacy of HBOT is viable.

Participants needed: 50
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Updated: Apr 16, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years [+1]

Patients with a known contraindication for HBOT: untreated pneumothorax; epileps... [+3]

Status: Recruiting

CERAMENT G Device Registry

This is an Observational Device Registry Study of CERAMENT\|G in normal use in accordance with the IFU. It will run for a period of three years from enrolment of the first patient into the Study at each Site, before being subject to review. A Device Registry is a form of observational study that concerns the performance of a device in normal use. It is intended to collect data that is reflective of 'real world' device performance.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: BONESUPPORT ABUpdated: Sep 26, 2025Locations: 3Duration: 12 Months
Eligibility criteria

18 years and over (on the day of surgery) [+2]

Any exclusion criteria as per IFU for CERAMENT|G [+1]

Status: Not yet recruiting

External Fixator or Antibiotic-coated Plate in Severe Open Long Bone Fractures

The purpose of the study is to assess whether infection rate is reduced with use of antibiotic-coated plate in severe open tibial fractures compare to use of external fixators

Participants needed: 178
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Oluwasegun AremuUpdated: Jan 5, 2024Locations: 2
Eligibility criteria

Age ≥ 18yrs, [+3]

Patients with traumatic brain injury, [+7]